Radio and PodcastRadio and PodcastLive Radio & Podcasts
143 - Diacerein 1% for Epidermolysis Bullosa; epoetin alfa biosimilar; MRI with reduced scan time; Gilenya® for pediatric relapsing MS artwork
Science & Medicine

143 - Diacerein 1% for Epidermolysis Bullosa; epoetin alfa biosimilar; MRI with reduced scan time; Gilenya® for pediatric relapsing MS

New FDA Approvals

May 16, 201807:30Science & Medicine

143 - Diacerein 1% for Epidermolysis Bullosa; epoetin alfa biosimilar; MRI with reduced scan time; Gilenya® for pediatric relapsing MS is an episode from New FDA Approvals. This science & medicine episode is made for lis...

About This Episode

143 - Diacerein 1% for Epidermolysis Bullosa; epoetin alfa biosimilar; MRI with reduced scan time; Gilenya® for pediatric relapsing MS is an episode from New FDA Approvals. This science & medicine episode is made for listeners who follow Ne...

Podcast

This episode belongs to New FDA Approvals.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published May 16, 2018, 07:30 long, audio available.